Feedback / Questions
Gazyva (obinutuzumab) - Roche, Biogen
OBINUSS: Obinutuzumab in Systemic Sclerosis
(clinicaltrials.gov)
-
Sep 26, 2026 -
P2 | N=120 | Not yet recruiting | Sponsor: Assistance Publique - Hôpitaux de Paris
New P2 trial
•
Immunology • Scleroderma • Systemic Sclerosis
http://clinicaltrials.gov/ct2/show/NCT07842523
Sep 26, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next